You are here:

Valens GroWorks Signs "MOU" With Okanagan Interventional Pain Clinic

VANCOUVER, Oct. 31, 2017 /CNW/ –Â Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), is pleased to announce the signing of a Memorandum of Understanding (“MOU“) with the Bill Nelems Pain and Research Centre, operating the Okanagan Interventional Pain Clinic, to form a strategic alliance for the purpose of conducting clinical research and development of safe, efficacious and reliable pharmaceutical-grade medicinal cannabis products (CBD and THC combinations) specific for the treatment of particular conditions.

The Bill Nelems Pain and Research Centre (“BNPRC“) serves as the main referral pain centre for approximately 750,000 patients within the Interior Health region, as well as patients from the Northern Health region in British Columbia. This centre specializes in comprehensive pain care, including cutting-edge interventional options, and interdisciplinary pain management.

Tyler Robson, CEO of Valens stated, “It is a great honour to forge this alliance with BNPRC, and an opportunity to realize our